For funding related to stock acquisition, 1.8 billion yen was borrowed from Resona Bank. Loan term is 10 years, interest is variable, no collateral, financial covenants require a net asset level of at least 75% of the previous year, two consecutive years of ordinary profit, and DSCR of at least 1.1x.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4492","jir_company_name":"Genetech Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-19","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4492-20260819-01.pdf","jir_short_summary":"For funding related to stock acquisition, 1.8 billion yen was borrowed from Resona Bank. Loan term is 10 years, interest is variable, no collateral, financial covenants require a net asset level of at least 75% of the previous year, two consecutive years of ordinary profit, and DSCR of at least 1.1x.","jir_summary":"### Contract overview\nThe company will borrow 1.8 billion yen from Resona Bank to finance the stock acquisition. Loan execution is on August 21, 2026; term is 10 years; interest is a floating rate (base rate + spread); there is no collateral or guarantee. The financial covenants specify maintaining consolidated net assets at 75% or more of the prior-year level, sustaining consolidated ordinary income in positive territory for two consecutive periods, and maintaining a DSCR of at least 1.1x from the fiscal year ending March 2028 onward.\n\n### Outlook and impact\nThe impact of this agreement on the company's consolidated results for the fiscal year ending March 2027 is expected to be minor, and the financing supports financial stability and future capital policy execution.","jir_financial_highlights":"Borrowed amount: 1.8 billion yen (Unknown)\nLender: Resona Bank, Ltd. (Unknown)\nLoan execution date: August 21, 2026 (Unknown)\nLoan term: 10 years (Unknown)\nInterest rate: Floating rate (base rate + spread) (Unknown)\nCollateral\/Guarantee: Unsecured, non-guaranteed (Unknown)\nFinancial covenants 1: Consolidated net assets maintained at 75% or more of the prior year (Unknown)\nFinancial covenants 2: Consolidated ordinary income not to be negative for two consecutive periods (Unknown)\nFinancial covenants 3: Maintain DSCR at 1.1x or higher (from the fiscal year ending March 2028 onward) (Unknown)","jir_category":"","jir_hashtags":"#Genetech, #Fundraising, #FinancialContract","jir_key_figures":"Borrowed amount: 1.8 billion yen (if unknown, use 'Unknown')\nLoan execution date: August 21, 2026\nLoan term: 10 years","jir_meta_title":"[Genetech] Announcement of Conclusion of a Monetary Loan Agreement Related to Fundraising | August 2026","jir_meta_description":"Genetech Corporation executes an 1.8 billion yen loan from Resona Bank. 10-year term, unsecured and non-guaranteed, with covenants requiring asset preservation, sustained profitability, and DSCR maintenance. Explaining impacts and outlook.","jir_og_title":"[Genetech] Conclusion of a Monetary Loan Agreement for Fundraising | August 2026","jir_og_description":"Genetech executes an 1.8 billion yen loan. 10 years, floating rate, unsecured and non-guaranteed. Financial covenants include asset preservation, continued profitability, and DSCR maintenance.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59859,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-105428","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n